Global Retirement Partners, LLC Aerie Pharmaceuticals Inc Transaction History

Global Retirement Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$7.02 - $13.33 $11,660 - $22,141	-1,661 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$15.16 - $18.97 $75 - $94	-5 Reduced 0.3%	1,661 $27,000
Q1 2021 Apr 14, 2021	BUY	$13.12 - $20.9 $11,007 - $17,535	839 Added 101.45%	1,666 $30,000
Q2 2020 Jul 13, 2020	BUY	$12.0 - $16.13 $2,292 - $3,080	191 Added 30.03%	827 $12,000
Q1 2020 Apr 28, 2020	BUY	$11.84 - $25.52 $426 - $918	36 Added 6.0%	636 $9,000
Q4 2019 Jan 23, 2020	BUY	$17.72 - $25.1 $2,569 - $3,639	145 Added 31.87%	600 $15,000
Q3 2019 Nov 19, 2019	BUY	$18.41 - $28.0 $8,376 - $12,740	455 New	455 $9,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.